Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Catabasis Pharma (CATB)

Catabasis Pharma (CATB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Catabasis Pharma One Kendall Square Bldg. 1400E Suite B14202 Cambridge MA 02139 USA

P: 617-349-1971 F: 617-273-2637

Description:

Catabasis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of therapeutics for treatment of inflammatory, immunological and metabolic diseases. Its product development pipeline includes CAT-1004, CAT-2000 series including CAT-2054 and CAT-2003, CAT-4001 as well as various programs which are in different clinical-stage. Catabasis Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 73,652
Shares Outstanding, K 11,617
Annual Sales, $ 0 K
Annual Net Income, $ -25,870 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,130 K
60-Month Beta 1.73
% of Insider Shareholders 3.20%
% of Institutional Shareholders 37.26%
Float, K 11,245
% Float 96.80%

Growth:

1-Year Return 0.83%
3-Year Return -87.19%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/08/19
Earnings Per Share ttm -2.89
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 69.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 12/31/18

CATB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.05
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -59.06
Return-on-Assets (Before Tax) -53.31
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.01
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.60
Book Value/Share 3.77
Interest Coverage -257.70
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar